Effective Genetic Vaccination with a Widely Shared Endogenous Retroviral Tumor Antigen Requires CD40 Stimulation during Tumor Rejection Phase

V. Bronte, S. Cingarlini, E. Apolloni, P. Serafini, I. Marigo, C. De Santo, B. Macino, O. Marin, P. Zanovello
2003 Journal of Immunology  
doi:10.4049/jimmunol.171.12.6396 pmid:14662838 fatcat:d6e3kak3nngjhj4uv5l7djrlia